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Abstract
Replication of human influenza A/H3N2 and A/H1N1 viruses was studied in human CACO-2 cells, a continuous line of intestinal
epithelial differentiated cells. Hemagglutinin (HA) was cleaved in these cells by an endogenous protease. Thus, infectious virus was
produced that underwent multiple cycle replication and plaque formation in the absence of trypsin added to the media. Cleavage of de
novo-synthesized HA occurred at a late stage of the exocytic pathway as indicated by pulse-chase labeling and by experiments employing
endoglycosidase H and brefeldin A treatment. However, surface-labeling experiments employing biotinylation suggested that there is no
cleavage at the plasma membrane. Unlike HA of serotypes H5 and H7 cleaved at multibasic cleavage sites by furin, the HAs with monobasic
cleavage sites analyzed here were not cleaved in CACO-2 cells in the presence of aprotinin, a natural inhibitor of trypsinlike proteases.
Growing CACO-2 cells were able to cleave HA of incoming virus, although influenza virus activating protease was not detected in culture
medium. These observations indicate that the activating enzyme of CACO-2 cells is a trypsinlike protease functioning in the trans-Golgi
network and presumably endosomes. In support of this concept immune staining with antibodies specific to human and bovine trypsin
revealed the presence of a trypsinlike protease in CACO-2 cells. Unlike MDCK and CV-1 cells undergoing rapid apoptosis after influenza
virus infection, CACO-2 cells showed no apoptosis but displayed cytopathic effects with necrotic signs significantly later after infection.
It follows from these data that, depending on the cell type, influenza virus may kill cells either by apoptosis or by necrosis.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Hemagglutinin (HA), the major envelope glycoprotein of
influenza A virus, mediates attachment to cell receptors and
virus entry into target cells. HA is composed of two sub-
units, HA1 and HA2, that are generated from the precursor
HA0 by proteolytic cleavage. Cleavage that is exerted by
host proteases activates virus infectivity and has been
shown to be an important determinant of influenza virus
pathogenicity (Klenk and Garten, 1994; Steinhauer, 1999).
The prime characteristic of HA that determines its sen-
sitivity to host proteases (influenza virus activating pro-
teases, IAP) is the cleavage site, which consists of either a
single arginine (monobasic site) or an R-X-K/R-R motif
(multibasic site) (Klenk and Garten, 1994). The cleavage
site is exposed in a peptide loop at the surface of the HA
spike (Chen et al., 1998), and its accessibility to the cleav-
age enzyme may be modulated by an adjacent carbohydrate
side chain (Kawaoka et al., 1984; Ohuchi et al., 1989). The
multibasic site is found only with some H5 and H7 strains,
whereas all other influenza A viruses as well as influenza B
and C viruses contain HAs with monobasic sites (Klenk and
Garten, 1994). As a rule, influenza viruses having multiba-
sic sites are highly virulent and induce systemic infection in
their avian hosts, whereas viruses with monobasic sites are
less virulent and provoke local inflammation in the respira-
tory tract (Klenk and Garten, 1994; Steinhauer, 1999).
HAs with multibasic cleavage sites are activated in the
trans-Golgi network by furin or related proproteinconverta-
ses (Stieneke-Gro¨ber et al., 1992; Morsy et al., 1994). HAs
containing monobasic cleavage sites are activated by trypsin
or trypsinlike proteases (Klenk et al., 1975; Lazarowitz and
Choppin, 1975), such as plasmin (Lazarowitz et al., 1973);
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kallikrein; urokinase; thrombin (Scheiblauer et al., 1992);
blood clotting factor Xa (Gotoh et al., 1990); acrosin (Gar-
ten et al., 1981); tryptase Clara (Kido et al., 1992, 1999);
miniplasmin from rat lungs (Murakami et al., 2001); pro-
teases from human respiratory lavage (Barbey-Morel et al.,
1987); and proteases secreted from bacteria, such as Staphy-
lococcus aureus (Tashiro et al., 1987) and Pseudomonas
aeruginosa (Callan et al., 1997). Cleavage by these pro-
teases is thought to occur either at the plasma membrane or
in extracellular fluids. Furthermore, evidence has been ob-
tained that the hemagglutinin of the A/WSN/33 (H1N1)
strain is cleaved in MDBK cells after virus internalization
by an unknown, presumably endosomal, protease (Boycott
et al., 1994).
A fair amount of information is available on the effects
of protease inhibitors on HA activation. Peptidyl-chloro-
methylketones mimicking furin-specific cleavage sites, such
as decREKR-CMK, have been shown to suppress HA cleav-
age by furin in cultured cells (Garten et al., 1989; Stieneke-
Gro¨ber et al., 1992). Several inhibitors of trypsinlike pro-
teases, such as -aminocaproic acid, an inhibitor of
plasminogen activation (Goto and Kawaoka, 1998; Zhirnov
et al., 1982b); aprotinin (Zhirnov et al. 1984); leupeptin
(Tashiro et al., 1987); pulmonary surfactant (Kido et al.
1993); and human mucus protease inhibitor (Beppu et al.,
1997), were found to possess antiviral potential by interfer-
ing with cleavage at monobasic sites in cultured cells sup-
plemented with blood serum, in chicken embryos, and in
lungs of infected mice.
Influenza infection triggers apoptosis in infected cells
(Hinshaw et al., 1994; Takizawa et al., 1993). There is
evidence that influenza apoptosis is a multifactorial process,
involving the FAS-dependent caspase 8 pathway (Balachan-
dran et al., 2000), the PKR/NF-kappaB/INF cascade (Zhir-
nov et al., 2002a), transcription factor c-Jun/AP-1, and cy-
tokine TGF- (Lin et al., 2001). Several viral proteins have
been shown to be involved, too. The nonstructural protein
NS1 down-regulates apoptosis in infected cells in an IFN-
dependent manner (Zhirnov et al., 2002a). The ion channel
protein M2 and the nucleocapsid protein NP were observed
to be specifically cleaved during apoptosis by host cell
caspases (Zhirnov et al., 1999, 2002a). It was also suggested
that proteins NA (Morris et al., 1999) and M1 (Zhirnov et
al., 2002b) may participate in regulation of apoptosis. Re-
cently, the interesting observation has been made that in an
epithelial cell line derived from porcine lung (SJPL) (Seo et
al., 2001) and some human bronchiolar cell lines (Arndt et
al., 2002) influenza virus infection does not lead to apopto-
sis but probably to necrosis. These data suggest that death
mechanisms in cells infected with influenza virus depend on
the host. However, host and viral factors that determine
death mechanisms remain so far unknown.
We report here that CACO-2 cells that develop in culture
into differentiated enterocytes resembling a natural intesti-
nal epithelium (Pinto et al., 1983; Jumarie and Malo, 1991)
are an efficient host system for productive growth of human
influenza A viruses. These cells are interesting in two re-
spects. First, they are able to cleave and, thus, to maintain
multicycle replication of human influenza A viruses. Cleav-
age of HA was sensitive to aprotinin, indicating that the
endogenous CACO-2 enzyme is a trypsinlike serine pro-
tease. Second, infected CACO-2 cells showed no apoptosis,
and necrotic markers were dominant in CACO-2 cells at late
stages of infection. These data show that cell killing by
influenza virus varies in different cell types and may de-
velop through apoptosis or necrosis.
Results
Proteolytic activation of hemagglutinin with monobasic
cleavage site in CACO-2 cells
First we compared multicycle replication of human in-
fluenza A/Aichi/68 and A/PR/8/34 viruses in CACO-2 and
MDCK cells. The results with Aichi virus are shown in Fig.
1A and B, and similar data were obtained with PR8 virus
(not shown). Multicycle replication and accumulation of
significant amounts of virus in culture fluid were found to
develop in CACO-2 cells, whereas virus replication in
MDCK cells was observed only after the addition of trypsin
to the culture medium. Under single-cycle growth condi-
tions, CACO-2 cells produced virus to similar titers as
MDCK cells, but growth rates were slower, and CACO-2
cells retained viability for a longer period then MDCK cells
(Fig. 1A). In the next set of experiments formation of viral
foci under agarose overlayer was studied in both cells. Viral
foci were formed in CACO-2 cells, whereas they developed
in MDCK cells only when trypsin was present in the aga-
rose layer (Fig. 1B). These observations suggest that
CACO-2 cells are able to activate HA by proteolytic cleav-
age and thus permit multicycle virus replication. Polypep-
tide patterns of influenza viruses synthesized in CACO-2
cells were therefore analyzed by PAGE, and virus infectiv-
ity was measured by double plaque assay. The results show
that virus grown in CACO-2 cells has 80–90% of its HA in
cleaved form and that the real infectivity of this virus is
almost as high as the potential one (Fig. 1C and Table 1 ).
In contrast, virus produced in MDCK cells contained ex-
clusively uncleaved HA and had low real infectivity that
was readily activated by trypsin cleavage of HA (Fig. 1C
and Table 1). These data show that CACO-2 cells contain a
protease able to activate HA with a monobasic cleavage site.
Cultured CACO-2 cells are known to differentiate during
proliferation. First growing as islets, they differentiate after
confluence by acquiring functional properties of entero-
cytes, including secretory activity (Pinto et al., 1983; Ju-
marie and Malo, 1991). To find out whether the ability to
cleave HA depends on differentiation, influenza viruses
were grown in young CACO-2 cultures (70% confluency)
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Fig. 1. Characteristics of influenza virus replication and viral polypeptides patterns in CACO-2 and MDCK cells. Cultures of CACO-2 and MDCK cells were
infected with Aichi and PR8 viruses at a MOI of 0.005 (A1), 2 (B–E), or about 5 (A2) PFU/cell and then incubated in medium with or without 0.1 g/ml
of trypsin. After different intervals virus yields in culture medium were evaluated by hemagglutination titration. Samples of purified virus were prepared from
culture fluids at 20 (MDCK) and 30 h.p.i. (CACO-2) and analyzed by PAGE followed by gel staining with Coomassie Blue R-350 (C). To study the ability
of viruses to produce foci, CACO-2 and MDCK cells were grown in 24-well plates and infected with different dilutions of Aichi virus. Infected cells were
covered with 1% agarose either lacking trypsin or containing trypsin (Tr). Viral foci were stained at 38 h.p.i. by antivirus antibodies, HRP conjugates and
insoluble TMB reagent. Young (Y) and aged (A) CACO-2 cells were infected with Aichi (D) and PR8 (E) viruses. At 28 h.p.i. viruses from culture fluid
and cell pellets were analyzed by PAGE-WB. WBs were scanned, and the HA0/HA1 ratios were calculated by the TINA program, version 2.09. Cytopathic
effects (c.p.e.) in cell monolayer were estimated visually as the amount of detached cells (“” shows one-third of the monolayer).
and in aged cultures (1 week after confluency), and the viral
polypeptides patterns were analyzed (Fig. 1D and E). Al-
though the amount of cleaved HA was higher in virions than
in cells, the age and thus the differentiation of the cells had
no marked effect on HA cleavage.
We then looked at the cleavage process in more detail.
When analyzed by pulse-chase labeling, first only the un-
cleaved glycoprotein HA0 was detectable in pulse-labeled
infected cells (Fig. 2A). The cleavage products HA1 and
HA2 were identified after 70 min and increased after 2.5 h
chase. Subunit HA1 of Aichi/2/68 virus was not clearly seen
on this gel since it comigrated with NP. To obtain more
information on the cleavage enzyme we tested the effect of
different protease inhibitors, such as -aminocaproic acid,
an inhibitor of plasminogen activation (Brockway and Cas-
tellino, 1971); aprotinin (6 kDa), a natural inhibitor of
trypsinlike proteases (Fritz and Wunderer, 1983); 2-mac-
roglobulin (725 kDa); 1-antitrypsin (53 kDa); protease
inhibitors from human plasma (Travis and Salvesen, 1983);
and ovomucoid (28 kDa), a trypsin inhibitor from hen egg
white (Tomimatsu et al., 1966) (not shown). Cycloheximide
was also used as an inhibitor of protein synthesis. Infected
cells were pulse-labeled and then incubated with the inhib-
itors during a 2.5-h chase period. Only aprotinin (0.1 mg/
ml) was found to suppress HA0 cleavage in infected
CACO-2 cells (Fig. 2A), whereas cycloheximide and other
antiproteases, such as -aminocaproic acid, 1-antitrypsin,
2-macroglobulin, and ovomucoid at concentrations as high
as 0.2, 0.35, 0.5, and 0.2 mg/ml, respectively, were not
effective (not shown). Since low-molecular-weight aproti-
nin inhibits cleavage, whereas the high-molecular-weight
inhibitors 1-antitrypsin and 2-macroglobulin, which have
a similar specificity, do not, it appears that cleavage occurs
inside cells. We have also analyzed whether 0.45 M sucrose,
which is an effective suppressor of clathrin-dependent en-
docytosis (Heuser and Anderson, 1989), interferes with the
inhibitory activity of aprotinin (Fig. 2B). When CACO-2
cells were incubated with sucrose, aprotinin retained the
ability to inhibit cleavage, implying that it entered infected
cells in a clathrin-independent manner. Taken together,
these data support the view that HA generated in CACO-2
cells is cleaved within cells by a trypsinlike protease. The
inability of cycloheximide to inhibit cleavage suggests a
preexisting pool of this protease in CACO-2 cells.
To test the effect of aprotinin on virus replication,
CACO-2 cell cultures were infected with different dilutions
of Aichi virus and then overlayed with agarose containing
or not containing aprotinin. Viral foci were analyzed at
46 h.p.i. (Fig. 2C). It can be seen, that normal foci about 1–2
mm in diameter developed in control wells, whereas in cells
covered with aprotinin agarose foci were significantly re-
duced in size and number. Similar observations were made
with PR8 virus (not shown). These data support the concept
that aprotinin interferes with multicycle virus replication.
Cleavage occurs in exocytotic and endocytotic
compartments of CACO-2 cells
We have then investigated the subcellular compartmen-
talization of HA cleavage. For this purpose two parameters
were analyzed. First, cleavage was investigated in CACO-2
cells incubated in the presence of brefeldin A (BFA), known
to cause disassembly of cis and medial Golgi compartments
and to inhibit the anterograde transport of proteins along the
secretory pathway (Lippinscott-Schwartz et al., 1989). Sec-
ond, the glycosylation patterns of HA0, HA1, and HA2
were tested by endoglycosidase-H (endoH) treatment. Be-
cause N-glycosylated proteins acquire endoH resistance in
the medial Golgi, endoH sensitivity is a characteristic for
glycoproteins that have not yet reached this compartment.
Both parameters were investigated in pulse-chase experi-
ments with Aichi and PR8 virus-infected CACO-2 cells. As
shown in Fig. 2A, BFA prevented cleavage indicating that
this process occurred in a trans-Golgi compartment or at the
plasma membrane. Next we incubated labeled cells with
peptidyl-N-acetylglucosaminidase F (PNAGase-F) to iden-
tify the electrophoretic positions of the fully deglycosylated
products HA0f, HA1f, and HA2f (Fig. 2D). PNAGase treat-
ment did not affect electrophoretic mobility of Aichi HA2
because HA2 of this mouse-adapted variant has lost its
glycosylation site by the substitution of Asn at position 154
for Thr as indicated by nucleotide sequence analysis (data
not shown). It has to be pointed out that most of uncleaved
HA labeled by a 40-min pulse was fully sensitive to endoH
as indicated by the major band HA0h, representing the
deglycosylated polypeptide. The minor band HA0h* prob-
ably represents HA containing both mannose-rich (endoH-
sensitive) and complex (endoH-insensitive) carbohydrates.
After 70- and 150-min chase periods, when HA1 and HA2
appeared, only minor fractions of HA0 and HA1 were
endoH sensitive. The results show that HA is cleaved during
or after its passage through the trans-Golgi region when
complex glycosylation is completed. Similar data were ob-
tained with PR8 virus (data not shown).
Further experiments have been done to find out if clea-
vage occurs before or after exposure of HA at the plasma
membrane of infected CACO-2 cells. In the latter case the
Table 1
Real and potential infectivitya of influenza viruses grown in CACO-2
and MDCK cells
Host cells Aichi/68 PR/8/34
Real Potential Real Potential
CACO-2 1.2  107 2.2  107 0.7  107 1.0  107
MDCK 1.6  104 3.0  107 0.8  104 1.7  107
a CACO-2 and MDCK cells were infected with Aichi/68 and PR/8/34
viruses at m.o.i. about 1 PFU/cell. Infectivity titers of culture fluids (PFU/
ml) were measured at 24 h.p.i. by two plaque assays, modified and stan-
dard, showing real and potential virus infectivity, as described (Zhirnov et
al., 1982a).
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Fig. 2. Effect of protease inhibitors and brefeldin A on intracellular HA0 cleavage and sensitivity of viral glycoproteins to glycosidases. (A,B, and D) CACO-2
cells were infected with Aichi virus at a MOI of 2 PFU per cell. At 6.5 h.p.i. infected cells were labeled for 40 min (pulse) and then incubated for 70 and
150 min in DMEM containing on excess of cold amino acids (chase) and the following inhibitors: 0.1 mg/ml of aprotinin, 10 g/ml BFA, and 75 M
cycloheximide (CHX). In separate experiment (B) infected cells were pulse-labeled (pul40) and chased in medium alone (none) or in medium containing 0.1
mg/ml of aprotinin (APR) or 0.45 M of sucrose (Suc). Viral polypeptides were immunoprecipitated and analyzed by PAGE followed by autoradiograpgy.
Some samples were pretreated with endo-H and PNGase-F before PAGE (D). (C) CACO-2 cells were infected with different dilutions of Aichi virus after
infection cells were covered either with standard agarose layer (none) or with agarose containing 0.1 mg/ml of aprotinin (apr). At 45 h.p.i. cells were fixed
and immunostained with True Blue dye, as described under Materials and methods.
proportion of cleaved to uncleaved HA should be higher on
the surface than in whole cells. Viral glycoproteins localized
on the cell surface were therefore labeled with nonperme-
able Biotin-NHS-sulfo cross-linking reagent, and the HA0/
HA1 ratios at the cell surface, in whole cells, and in virions
were compared (Fig. 3A and Fig. 1D and E). The ratios
were similar at the plasma membrane and in whole cells,
indicating the lack of marked cleavage at the plasma mem-
brane of infected CACO-2 cells. Furthermore, the ratio of
biotinylated HA0/HA1 in plasma membranes was higher
than that in virions. This result may be explained either by
a more effective incorporation of cleaved HA into virions or
additional cleavage in extracellular virus.
The ability to cleave at a single arginine suggested that
IAP of CACO-2 cells is a trypsinlike protease. We have
therefore tested CACO-2 cells for the presence of such an
enzyme by immunostaining with antibodies developed
against human and bovine trypsin. The results obtained with
mock-infected CACO-2 cells and antihuman trypsin anti-
bodies are shown in Fig. 4B. Similar results were obtained
in influenza-infected CACO-2 cells (not shown). It can be
clearly seen that CACO-2 cells contain a trypsinlike protein.
The most intensive staining was observed in polarized cells
forming domes (Fig. 3B; arrow), whereas other cells were
less stained, suggesting that expression of the protease de-
pended on the differentiation of cells. Permeabilization with
the nonionic detergent Nonidet P-40 increased staining in-
tensity suggesting intracellular accumulation of the trypsin-
like protease. Similar results were obtained in CACO-2 cells
with antibovine trypsin antibodies. However, there was no
immunostaining of non-HA-activting human epitelial Hep-2
cells and monkey CV-1 cells with either antihuman or
antibovine trypsin antibodies (not shown). Thus, there is a
good correlation between HA cleavage and the presence of
the trypsinlike protein, suggesting that this is the activation
enzyme of CACO-2 cells.
The above experiments have shown that HA cleavage in
the CACO-2 cell line is associated with cells but they did
not exclude cleavage in the culture medium. To test if
extracellular cleavage occurs, the following experiments
were done. Aichi virus was grown in MDCK cells without
Fig. 4. CACO-2 cells are able to cleave HA upon virus entry. Aichi virus
grown in MDCK cells was used as reference virus containing HA0. (A)
This virus was incubated for 3 h at 37°C with growing CACO-2 cells. After
incubation a virus pelleted from culture medium (medium) and cells
removed from matrix (cell) were analyzed by PAGE-WB. (B) Reference
virus was incubated with homogenates of CACO-2 cells and with concen-
trated culture medium of mock-infected CACO-2 cells. Virus incubated
with cell homogenate (cell.hom.) or medium concentrate (med.conc.) was
applied directly to PAGE-WB. Lanes: none and trypsin-initial reference
virus nontreated and treated in vitro with trypsin, respectively.
Fig. 3. Cell surface biotinylation labeling (A) and immune detection of
trypsin-like protease (B) in CACO-2 cells infected with influenza A vi-
ruses. (A) CACO-2 cells were infected with Aichi and PR8 viruses at a
m.o.i. of 4 PFU per cell and incubated for 8.5 h. Aichi and PR8 viruses
grown in chicken eggs and infected CACO-2 cells were labeled with
nonpermeable biotin–NHS–sulfo agent for 35 min at 4°C. After labeling,
virus (E virus) and cells (cell-Bt) were desintegrated, and viral proteins
were precipitated with antiviral antibodies and protein G–Sepharose. Im-
mune complexes were analyzed by PAGE-WB, using streptavidin–HRP
conjugate and ECL. WBs were scanned, and the HA0/HA1 ratios were
calculated by the TINA program, version 2.09. (B) CACO-2 cells were
fixed with paraformaldehyde, incubated either without () or with ()
antihuman trypsin antibodies, followed by visualization of protease–anti-
body complexes with secondary species-specific HRP conjugate and in-
soluble TMB substrate (True Blue), and observed in the light microscope.
The “dome” structure is shown by an arrow.
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trypsin. As expected it contained predominantly uncleaved
HA and had low real infectivity (Fig. 1C and Table 1).
CACO-2 cultures were incubated with this virus for 3 h.
Thereafter, virus in the culture medium and in pelleted cells
was analyzed by PAGE to study HA cleavage. Virus re-
maining in culture medium did not display an increased
amount of cleaved HA (Fig. 4A; medium). However, there
was a clear cleavage increase on cell bound virus after the
3-h incubation period (Fig. 4A; cell). These results suggest
that (1) IAP is not released from CACO-2 cells to cleave
HA on free extracellular virions and (2) IAP is a cell-
associated enzyme that can cleave HA on input virus after
adsorption.
Next, we have analyzed whether a homogenate prepared
from CACO-2 cells will cleave HA and activate virus in-
fectivity. Nonactivated Aichi virus grown in MDCK cells
was again used as reference virus. Homogenates were pre-
pared from mock-infected and A/WSN/33-infected
CACO-2 cells at 7.5 h.p.i. In addition to homogenates of
cells, culture medium concentrate was also tested in the
cleavage assay. Virus grown in MDCK cells was incubated
with homogenates for 3 h at 37°C and then analyzed by
PAGE (Fig. 4B). It was found that neither the cell homog-
enates nor the medium concentrate were able to cleave HA
(Fig. 3A and B) or to increase virus infectivity (not shown).
The failure to detect IAP in cell homogenates suggests that
structural integrity of the cellular compartment containing
the enzyme is essential for its activity.
Influenza virus infection causes necrosis of CACO-2 cells
We have observed here that influenza-infected CACO-2
cells retained viability for at least 3 days, whereas other
cells, such as MDCK and CV-1 cells, were killed already 1
day after infection. This prompted us to compare the mech-
anisms of cell death in these cell lines. Apoptotic and
necrotic markers were therefore investigated at different
intervals after virus infection. Cytopathic effects were as-
sessed by microscopic monitoring of rounding and detach-
ment of cells from support matrix and by Trypan blue
staining of dead cells. Visible cytopathic effects developed
in CACO-2 cells at 42–45 h.p.i. (about 10–30% of cells
were detached and dead at this stage), and about 60–80% of
cells were dead and detached from the supporting matrix by
70 h.p.i. In contrast, in MDCK (not shown) and CV-1 cells
almost total death and cell detachment were observed at
about 25 h.p.i. (Fig. 5A). Staining with Trypan blue showed
that 80–90% of cells still attached on the matrix were dead
at 20–22 h.p.i. in CV-1 and MDCK cells and at around
70 h.p.i. in CACO-2 cells (Fig. 5B).
Apoptosis was analyzed by five different approaches: (1)
monitoring chromatin DNA fragmentation (DNA laddering)
as a major indicator of apoptosis; (2) immuno staining of
cells with M30 monoclonal antibody, which selectively
recognizes apoptotic cytokeratin 18, a specific marker of
apoptosis, but does not stain necrotic cells (Leers et al.,
1999); (3) annexin-V binding to cell surface-exposed phos-
phatidylserine (PS), which is specific for early apoptosis
lacking necrosis, whereas after necrotic plasma membrane
permeabilization annexin-V binds also to intracellular PS
(Martin et al., 1995); (4) proteolytic activation of caspases
3, 8, and 9; and (5) caspase-dependent cleavage of nucleo-
capsid protein NP occurring during apoptosis (Zhirnov et
al., 1999). Additionally, PI staining of infected cells has
been used to estimate the level of cell plasma membrane
leakage as one of the main hallmarks differentiating necro-
sis from apoptosis (McGahon et al., 1995).
In accordance with our earlier observations (Zhirnov et
al., 1999, 2002a), MDCK and CV-1 cells infected with
Aichi or PR8 viruses were killed at 20–24 h.p.i., showing
DNA fragmentation (Fig. 5C); accumulation of the apopto-
tic form of NP (aNP) (Fig. 5D); and cleavage of caspases 3,
8, and 9 (Fig. 5E). After PI staining, only a few CV-1 cells
were found to be stained at 20 h.p.i., showing the absence of
necrosis and supporting the notion that apoptosis is the main
death mechanism of these cells (Fig. 5F).
In all of these aspects CACO-2 cells were markedly
different from MDCK and CV-1 cells. First, CACO-2 cells
were more resistant to influenza-mediated killing, and
prominent cell death developed only at 60–70 h.p.i. (Fig.
5A). Second, there were no marked apoptotic signs in in-
fluenza-infected CACO-2 cells, such as DNA laddering
(Fig. 5C); aNP accumulation (Fig. 5D); and apoptosis-spe-
cific staining with M30-cytodeath antibodies (Fig. 5H) at
the late stage of infection, when a prominent cytopathic
effect was seen. Additionally, cleavage of caspases 3, 8, and
9 was not detected in infected CACO-2 cells (Figs. 5C–E).
Host cell caspases are known to be activated by limited
proteolysis, and the following precursors and cleavage frag-
ments have been identified: p323p20p11 for caspase 3,
p553p42/343p20p10 for caspase 8, and p483p35p10
for caspase 9 (Boesen et al., 1998; Sun et al., 1999). The
cleavage products p20, p42, and p35 of caspases 3, 8, and 9,
respectively, were clearly seen in CV-1 cells and were not
detectable in CACO-2 cells as late as 60 h.p.i., when the
cytopathic effect developed. It was also noted that activation
cleavage of caspases 3, 8, and 9 was detectable only at the
terminal stage of cell death when almost all infected
CACO-2 cells were dead at around 70 h.p.i. (not shown).
These data suggest that signaling for caspase cleavage was
delayed in infected CACO-2 cells, and cell death preceded
such activation cleavage of host caspases. Third, unlike
influenza virus infection, treatment of CACO-2 cells with
staurosporine, a well-known inducer of apoptosis (Bertrand
et al., 1994), rapidly provoked apoptosis as indicated by the
appearance of DNA laddering (Fig. 5F) and significant
apoptosis staining of cells with M30 cytodeath antibodies
(Fig. 5H). This experiment shows that the apoptotic system
is functional in CACO-2 cells but is not activated during
influenza infection. Fourth, in contrast to MDCK and CV-1
cells, influenza-infected CACO-2 cells were intensively
stained with PI late after infection, indicative of necrotic
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Fig. 5. Death parameters in CACO-2, MDCK, and CV-1 cells infected with influenza A virus. CACO-2, MDCK, and CV-1 cells were infected with Aichi
(Ai) or PR8 (PR) viruses at a m.o.i. of about 2 PFU per cell. At 22 (MDCK and CV-1 cells) and 24, 46, and 72 h.p.i. (CACO-2 cells) infected cells were
examined by light microscopy (LM) for Trypan blue uptake (TB) (A and B); DNA laddering (C and F); aNP accumulation (D); the cleavage of caspases
3, 8, and 9 (E); and propidium iodide staining (G) as described under Materials and Methods. (C) U, uninfected cells; M, MW markers. (F) M, MW markers;
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U, uninfected cells; ST, uninfected cells incubated with staurosporine for 18 h, Ai, cells infected with Aichi virus for 60 h. (H and I) Mock-infected,
Aichi-infected (32, 48, and 58 h.p.i), and staurosporine-treated for 20 h (ST-20) CACO-2 cells were tested either with M30-cytodeath monoclonal antibodies
(H) or with annexin-V (I) procedures, respectively, and were visualized with “True Blue” substrate followed by light microscope observation. Amounts of
positive cells as a percentage of total cells are shown at the bottom.
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death (Fig. 5G). Fifth, increased annexin-V binding was
observed only late after infection (50–70 h.p.i.), whereas at
earlier stages (25–40 h.p.i.) annexin-V staining was found
to be comparable with the background of uninfected control
cells (Fig. 5I). However, when apoptosis was induced by
staurosporine, extensive annexin binding was observed in
CACO-2 cells (Fig. 5I; ST). The results obtained with
annexin-V indicate that there is no apoptosis in CACO-2
cells early after infection, whereas later cells become ne-
crotic, allowing annexin-V binding to intracellular PS.
Taken together, all of these observations indicate that most
of the cells in CACO-2 cultures are resistant to influenza-
mediated apoptosis and die through necrosis only late after
infection.
Discussion
The data presented in this article have shown that human
influenza A viruses containing hemagglutinin with a mono-
basic cleavage site are activated in CACO-2 cells. Virus
yields and replication rates in CACO-2 cells were similar to
those obtained in MDCK cells supplemented with trypsin.
CACO-2 cells are epithelial cells that differentiate sponta-
neously in culture during proliferation, and they exhibit
many functional properties of enterocytes (Pinto et al.,
1983; Jumarie and Malo, 1991). Before confluency, there
are islets containing mainly undifferentiated dividing cells,
whereas cells become polarized and differentiated when
cultures are confluent. Virus grown in young and aged cell
cultures contained predominantly cleaved HA. Thus, IAP
expression occurred already in young CACO-2 cells and
was not linked to cell differentiation and concomitant se-
cretory activity. In fact, there was no secretion of IAP into
the culture fluid of CACO-2 cells.
Cleavage of monobasic HA in CACO-2 cells takes place
at a late stage of the exocytic pathway. In this respect it
resembles cleavage of multibasic HA, which occurs in the
trans-Golgi network (Stieneke-Gro¨ber et al., 1992; Walker
et al., 1992). However, we show here that cleavage of
monobasic HA is probably accomplished by cell-associated
trypsinlike protease(s), whereas multibasic HA is cleaved
by the proproteinconvertase furin recirculating between the
trans-Golgi network and plasma membrane (Stroh et al.,
1999). Thus, both HA types may be cleaved in the same
intracellular compartment of CACO-2 cells, yet by different
proteases. Cell-associated cleavage of human influenza A
virus hemagglutinin has also been found in cultures of
human respiratory epithelium prepared from adenoid tissue
(Zhirnov et al., 2002c). Taken together these data suggest
that epithelial cells of human mucosa may contain intracel-
lular trypsinlike IAP(s) that can cleave monobasic hemag-
glutinin intracellularly and produce proteolytically activated
virions.
Our data show that CACO-2 cells are a suitable cell
culture system for production of high yields of infectious
influenza virus. Allowing effective HA cleavage and mul-
ticycle virus replication, CACO-2 cells may become a use-
ful tool for isolating virus from clinical specimens, for
selection of virus mutants generated by reverse genetics,
and for other applications. For instance, we have success-
fully used CACO-2 cells in reverse genetics experiments to
prepare influenza virus mutants containing NP with a mod-
ified caspase cleavage site (data not published). Further-
more, intestinal replication of many influenza A viruses,
including human epidemic viruses containing monobasic
HA, has been described in the intestine of pigs, ferrets, and
birds (Kawaoka et al., 1987; Slemons and Easterday, 1978;
Webster et al., 1978; Glathe et al., 1984). These observa-
tions are consistent with our present finding that enterocytes
have the ability to maintain influenza replication.
Exogenous aprotinin inhibits HA cleavage in infected
CACO-2 cells. This finding is interesting for several rea-
sons. First, the activity of aprotinin, an inhibitor of trypsin-
like serine proteases, indicates that human mucosal IAP
belongs to this group of proteases. Second, our data suggest
that aprotinin is internalized by clathrin-independent endo-
cytosis and transported to the intracellular cleavage com-
partment. Third, aprotinin may be a useful tool for therapy.
Previously we have shown that aprotinin suppresses HA
cleavage and virus activation in cultured cells (Zhirnov et
al., 1982b), chicken embryonated eggs (Zhirnov et al.,
1985), and mouse lungs (Zhirnov et al., 1984) and protects
against lethal influenza infection of mice (Ovcharenko and
Zhirnov, 1994; Zhirnov, 1987). Furthermore, therapeutic
efficacy against influenza and parainfluenza infections with-
out side effects (Zhirnov et al., 1994a, 1994b) has been
demonstrated in humans (Zhirnov et al., 1996). These ob-
servations are in agreement with earlier data showing that
aprotinin is able to inhibit respiratory proteases, such as
Tryptase Clara (Kido et al., 1992), miniplasmin (Murakami
et al., 2001), and plasmin (Zhirnov et al., 1982b), which
were considered to be involved in influenza virus activation
in mucosal membranes of the respiratory tract. Taken to-
gether these results additionally support our previous con-
cept that aprotinin is a potential anti-influenza drug (Zhir-
nov, 1983).
Influenza virus has been reported to provoke apoptosis in
many types of cells, such as epithelial Madin–Darby canine
kidney (MDCK) cells, epithelial mink lung cell (Mv1Lu)
cells, HeLa cells, chicken fibroblasts, monkey kidney
(VERO) cells, lymphocytes, and macrophages (Takizawa et
al., 1993; Hinshaw et al., 1994; Lowy and Dimitrov, 1997;
Morris et al., 1999; Zhirnov et al., 2002a). In contrast,
several epithelial cell lines originated from human (Arndt et
al., 2002) and porcine (Seo et al., 2001) lung have been
reported recently to die after influenza infection not through
apoptosis but probably through necrosis. Here we present
another cell line of intestinal origin that maintained effec-
tive virus replication but was resistant to rapid influenza-
mediated killing. When these cells were infected with in-
fluenza virus apoptotic markers were minimal and necrotic
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signs were dominant. Thus, death in influenza virus-infected
cells may develop not only via apoptosis but also through
necrosis. Interestingly, both apoptotic and necrotic changes
have been detected in cells infected with other viruses, such
as Semliki Forest virus, poliovirus, human herpesvirus type
7, and murine polyomavirus (Agol et al., 1998; An et al.,
2000; Glasgow et al., 1997; Secchiero et al., 1997; Nargi-
Aizenman et al., 2001). These data show that in virus-
infected cells apoptotic and necrotic changes may develop
in parallel and, depending on unknown factors, one of them
may become dominant. It is known that necrosis and apo-
ptosis may have common intracellular pathways in the ini-
tial signaling phase, such as -TNF receptor signaling and
FAS-mediated oligomerization of FADD by the DED do-
main. However, necrosis does not need caspase activities
(Matsumata et al., 2000). It is assumed that cell death
develops slowly in cells with caspase deficiency and that
such cells show necrosis rather than apoptosis (Lemaire et
al., 1998; Matsumata et al., 2000). Necrosis in influenza-
infected CACO-2 cells may therefore reflect insufficient or
delayed signaling for caspase activation. Our data showing
the lack of caspase activation cleavage in influenza-infected
CACO-2 cells support this concept. However, the exact
mechanisms leading to necrosis in influenza-infected
CACO-2 cells are not yet clear and remain to be determined.
Materials and methods
Cells and viruses
Influenza A/PR/8/34 (H1N1) virus (PR8) and a mouse
lung-adapted strain of A/Aichi/2/68 (H3N2) virus (Aichi)
were grown in 10-day-old embryonated chicken eggs (Zhir-
nov et al., 1985). Madin–Darby canine kidney (MDCK)
cells (Roche Products Ltd.), monkey kidney (CV-1) cells,
and a human epithelial colon carcinoma cell line (CACO-2)
(European Collection of Cell Cultures; ECACC) were pas-
saged in Dulbeco’s minimal essential medium (DMEM)
containing 10% bovine fetal calf serum (FCS) (Gibco/
BRL). CACO-2 cells were passaged at dilutions of 1:4 to
1:6. Monolayers became confluent after about 1 week and
could be maintained for several weeks.
Trypan blue exclusion assay
The number of dead cells was estimated by the Trypan
blue exclusion assay where viable cells exclude the dye,
whereas dead cells take up the dye and are stained. Infected
and mock-infected cell monolayers were incubated with
0.1% Trypan blue prepared in phophate-buffered saline
(PBS) for 30 min at 37°C. Then cells were washed with
PBS and photographed in a light microscope.
Propidium iodide (PI) staining of cells
Uninfected and influenza virus-infected cells grown on 1
cm2 coverslips were incubated in the darkness with DMEM
containing 2 g/ml of PI for 15 min and fixed with 2%
paraformaldehyde prepared in PBS at 4°C for 20 min. Fixed
cells were then washed twice with PBS, covered with
Moviol mount medium, and observed in a fluorescent mi-
croscope with a 600 EFLP filter.
Immune staining of cells with anticytokeratin 18
(M30 CytoDEATH) antibodies
Uninfected, influenza virus-infected and staurosporine-
treated CACO-2 cells grown on 4-well plates (Nunclon,
Denmark) were fixed with 2% paraformaldehyde prepared
in PBS for overnight incubation at 4°C and permeabilized
with PBS containing 0.1% of Nonidet P-40 for 15 min at
room temperature. Permeabilized cells were washed with
PBS and incubated for 1 h with a mouse monoclonal anti-
body (clone M30-CytoDEATH) (Roche) specific for an
epitope of the intracellular apoptotic form of cytokeratin 18
(Leers et al., 1999) at a dilution of 1:200 in PBS containing
0.5% of bovine serum albumin. Cells were then incubated
with horseradish peroxidase conjugated secondary antispe-
cies antibodies (Dako), followed by visualization of keratin-
positive cells with TMB insoluble substrate “True Blue”
(KPL). Stained slides were photographed in a light micro-
scope (magnification,100), and the percentage of positive
cells was counted.
Staining of cells with biotinylated annexin-V
Uninfected, influenza virus-infected (25, 36, and
58 h.p.i.), and staurosporine-treated (7.5 M for 20 h)
CACO-2 cells grown in 4-well plates were washed with
binding buffer (BB; 2.5 mM Hepes-NaOH, pH 7.4; 140 mM
NaCl; 5 mM CaCl2), incubated for 15 min with recombinant
biotinylated annexin-V (Biosource International; USA) di-
luted in BB 1:50, and then washed with BB. After that, cells
were fixed for 15 min with 2% paraformaldehyde prepared
ex-temporo in BB, washed with BB, and incubated for 30
min with horseradish peroxidase-conjugated streptavidin
(Amersham-Biotech, England), followed by visualization of
annexin-V-positive cells with TMB water-insoluble sub-
strate “True Blue” (KPL). Stained cells were observed in a
light microscope (magnification, 250).
Immune staining of cells with antitrypsin antibodies
Uninfected and influenza virus-infected CACO-2 cells
and human epithelial Hep-2 cells grown on 4-well plates
(Nunclon, Denmark) were fixed with 2% paraformaldehyde
prepared in PBS for overnight incubation at 4°C. Fixed cells
were washed with PBS and incubated for 1 h with IgG
fractions either of antibodies developed in rabbits against
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human trypsin (Calbiochem, USA) or of antibodies specific
for purified bovine trypsin (Sigma, USA) raised in guinea
pigs at the D. I. Ivanovsky Institute of Virology (Moscow,
Russia). Antibodies were diluted in PBS containing 0.5% of
bovine serum albumin from 1:100 to 1:400 in different
experiments. After washing with PBS cells were incubated
with horseradish peroxidase-conjugated secondary anti-IgG
rabbit or guinea pig species-specific antibodies (Dako).
Trypsinlike protease-positive cells were identified with
TMB-insoluble substrate “True Blue” (KPL) in a light mi-
croscope (magnification, 100).
Pulse-chase labeling and immune precipitation of cellular
polypeptides
CACO-2 cells were infected with influenza Aichi or PR8
viruses at a m.o.i. of about 4 PFU per cell. After 8.5 h.p.i.
cells were incubated for 40 min in MEM lacking cold
methionine/cysteine and containing S35-labeled methionine
and cysteine (Amersham) at a concentration of 75 Ci/ml
(pulse). Then about 106 cells were washed twice with MEM
containing the 10-fold amount of cold methionine and cys-
teine and were incubated in this medium for additional 1.5
and 3.0 h (chase). After labeling, the cells were mechani-
cally removed from the plate and pelleted. Cell pellets were
dissolved in 200 l of RIPA buffer containing 250 mM
NaCl, 50 mM Tris–HCl (pH 7.8), 0.4% nonionic detergent
NP-40, 250 M benzamidine, and 50 TIU/ml aprotinin and
centrifuged at 12,000g to remove undissolved debris.
Twenty- to forty-microliter aliquots of supernatant were
diluted in 250 1 PBS and mixed with antibodies raised in
rabbits against A/X31/82 (H3N2) hemagglutinin or A/PR/
8/34 virus. Samples were incubated for 1 h at room tem-
perature and then mixed with 25 l of a 40% suspension of
protein G–Sepharose (Pharmacia) and incubated for addi-
tional 45 min. Immune complexes were washed 5 times
with PBS and dissolved in SDS-containing dissociation
buffer. Samples were analyzed by PAGE followed by au-
toradiography on Kodak BioMax film.
Biotinylation of viral glycoproteins at the cell surface
Influenza virus-infected CACO-2 cells grown on 6-cm
dishes were washed 2 times to remove contaminating pro-
teins and then incubated twice at 20°C for 20 min each time
with 3 ml PBS containing 1 mg/ml nonpermeable biotin-
NHS-sulfo (Calbiochem), 5 mM CaCl2, and 2.5 mM
MgCl2. Cells were then incubated with 50 mM glycine
prepared in PBS to saturate the remaining biotinylation
reagent. Cells (106) were collected, suspended in 200 1
of PBS, and homogenized by ultrasonication. Fifty micro-
liters of cell homogenates were mixed with 350 1 of RIPA
buffer and clarified at 12,000g for 10 min. Viral glycopro-
teins were precipitated by rabbit antivirus antibodies bound
to protein G–Sepharose and analyzed by PAGE-WB fol-
lowed by identification of biotinylated viral glycoproteins
with streptavidin–HRP conjugate (Amersham-Biotech) and
enhanced chemiluminescence (ECL) (Pierce).
Polyacrylamide gel electrophoresis (PAGE)
Polypeptides were electrophoresed in 12% polyacryl-
amide gels using Tris–glycine–SDS buffer followed by
autoradiography as previously described (Zhirnov et al.,
1999). For gel staining with Coomassie brilliant blue R-350,
the protocol of Pharmacia was applied. For electrophoresis,
cellular polypeptides were treated in dissociation buffer (2%
SDS, 0.01 M dithiotreitol, 0.02 M Tris–HCl, pH 6.8) for 5
min at 96°C.
Western blot analysis (WB)
After SDS-PAGE the polypeptides were transferred from
the gel onto Protran-nitrocellulose membranes (pore size 
0.45 m) (Schleicher & Schuell) by semidry electroblotting
with a Tris–glycine buffer (pH 9.8) containing 15% eth-
anol. Membranes were washed with 150 mM PBS and
incubated overnight at 4°C in 5% dried milk in PBS. After
washing with PBS, membranes were incubated for 2 h at
room temperature in PBS containing 1% BSA, and rabbit
antisera specific for H3 hemagglutinin, PR8 virus, caspase 3
(Pharmingen), caspase 9 (Pharmingen), and caspase 8
(kindly given by Dr. Xiao-Ming Sun from the MRC Toxi-
cology Unit, University of Leicester, UK; Sun et al., 1999).
Mouse monoclonal antibodies against influenza virus NP
(clones A1 and A3; CDC, Atlanta) were also used. After
incubation with antibodies, membranes were exposed to
horseradish peroxidase-(HRP) conjugated secondary anti-
species antibodies (Dako), followed by visualization of pos-
itive bands by ECL on Kodak BioMax film.
Focus assay in MDCK cells
MDCK cells grown in 24-well plates were incubated
with 0.4 ml/well of 10-fold virus dilutions in PBS. After a
60-min incubation at room temperature, the virus inoculum
was removed, and cells were washed and covered with 1.5
ml of agarose (culture quality; Sigma) at a final concentra-
tion of 1% in DMEM containing 0.1% of BSA. In some
experiments, the agarose overlay contained 0.1 g/ml of
acetylated trypsin (Sigma) to permit virus activation and
secondary rounds of virus replication. Thirty-five to fifty
hours after infection, cells were fixed with 4% paraformal-
dehyde, and agarose layers were removed. Fixed cells were
incubated for 1 h with anti-influenza virus antibodies and
after that with HRP-conjugated secondary antispecies anti-
bodies (Dako), followed by visualization of virus foci with
TMB insoluble substrate “True Blue” (KPL). Stained foci
were counted.
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DNA fragmentation analysis
For the isolation of cellular low-molecular-weight DNA,
the SDS–high salt extraction method has been used (Zhir-
nov et al., 1999). Mock-infected and influenza-infected cells
were suspended in 80 1 PBS and gently mixed with 300
1 of buffer containing 10 mM Tris–HCl (pH 7.6), 10 mM
EDTA, and 0.6% SDS. In some experiments, cells were
incubated for 15–20 h with staurosporine (Sigma) at a
concentation of 7.5 M. Cell lysates were incubated over-
night at 4°C in 100 1 of 5 M NaCl and centrifuged at
14,000 rpm for 20 min at 4°C. Supernatants were treated
sequentially with RNAase A (1 mg/ml) and proteinase K
(0.2 mg/ml) for 20 min at 37°C, mixed with two volumes of
ethanol, and left overnight at20°C. Precipitated DNA was
resuspended in TE buffer (10 mM Tris–HCl, 1 mM EDTA,
pH 7.6), electrophoresed in 1.5% agarose–TBE buffer, and
stained with ethidium bromide.
HA cleavage in CACO-2 cell homogenates
CACO-2 cells (106) were removed from dishes with a
rubber policeman, pelleted at 1000g for 15 min, and sus-
pended in 50–70 1 of PBS. Cell suspensions were homog-
enized either by 20 frictions in a 1-ml syringe/24GA-1
needle or by ultrasonic disintegration for 2 min at 350 Wt
(Branson Sonifier 450). All manipulations were performed
at 4°C. To perform the HA0 cleavage test, influenza Aichi
or PR8 viruses were grown in MDCK cells, culture fluids
were clarified at 4,000g for 20 min, and viruses were pel-
leted through 5.0 ml of 20% (Wt/Wt) sucrose in PBS at
22,000 rpm for 2.5 h in a SW 27.1 rotor (Beckman). Virus
pellets were suspended in PBS, mixed with CACO-2 cell
homogenates, and incubated at 37°C for 3–4 h. After incu-
bation, the mixtures were analyzed by PAGE-WB with
virus-specific antibodies.
CACO-2 culture medium concentrate
Confluent CACO-2 cell cultures in 6-cm dishes were
incubated for 1 week at 37°C in 8 ml of DMEM lacking
FCS containing streptomycin and penicillin. Culture me-
dium was clarified at 3000g for 10 min and concentrated in
Centriplus 10 tubes (Amicon) with a cutoff value of 10 kDa.
The final volume of medium concentrate was about 80 1.
In cleavage experiments, 20 1 of concentrate (5–10 g of
protein) were mixed with 3 1 of purified virus ( 0.5 g
of protein), incubated for 3–4 h at 37°C and then analyzed
by PAGE-WB and plaque assay.
Double plaque assay
Plaque assays were performed in MDCK cells prepared
in 24-well plates. Real infectivity, i.e., of virions with
cleaved HA, was measured by a modified plaque assay,
whereas potential infectivity, which includes also virions
with uncleaved HAs, was measured by the standard plaque
method (Zhirnov et al., 1982a). Briefly, infected cells were
covered with 1 ml of 1% agarose (culture quality; Sigma) in
DMEM containing 0.3 g/ml of acetylated trypsin (Sigma)
in the case of standard plaque assay and no trypsin in the
modified plaque assay. According to the modified assay,
after 24 h of incubation at 37°C, the cells were overlaid
additionally with 0.7% agarose (0.5 ml per well) containing
0.8 g/ml of acetylated trypsin. In both plaque assays, cells
were stained 3 days after infection with hematoxilin-eosin,
and plaques were counted.
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